NO141898C - Fremgangsmaate for fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-piperazin-1-yl)-kinazolin - Google Patents

Fremgangsmaate for fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-piperazin-1-yl)-kinazolin

Info

Publication number
NO141898C
NO141898C NO744382A NO744382A NO141898C NO 141898 C NO141898 C NO 141898C NO 744382 A NO744382 A NO 744382A NO 744382 A NO744382 A NO 744382A NO 141898 C NO141898 C NO 141898C
Authority
NO
Norway
Prior art keywords
kinazoline
dimetoxy
furoyl
piperazin
amino
Prior art date
Application number
NO744382A
Other languages
English (en)
Norwegian (no)
Other versions
NO141898B (no
NO744382L (sv
Inventor
Hans-Jurgen Ernst Hess
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO744382L publication Critical patent/NO744382L/no
Publication of NO141898B publication Critical patent/NO141898B/no
Publication of NO141898C publication Critical patent/NO141898C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
NO744382A 1973-12-05 1974-12-04 Fremgangsmaate for fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-piperazin-1-yl)-kinazolin NO141898C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/421,992 US3935213A (en) 1973-12-05 1973-12-05 Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives

Publications (3)

Publication Number Publication Date
NO744382L NO744382L (sv) 1975-06-30
NO141898B NO141898B (no) 1980-02-18
NO141898C true NO141898C (no) 1980-06-04

Family

ID=23672938

Family Applications (1)

Application Number Title Priority Date Filing Date
NO744382A NO141898C (no) 1973-12-05 1974-12-04 Fremgangsmaate for fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-piperazin-1-yl)-kinazolin

Country Status (32)

Country Link
US (1) US3935213A (sv)
JP (1) JPS5093987A (sv)
AR (1) AR207766A1 (sv)
AT (1) AT342598B (sv)
BE (1) BE822873A (sv)
CA (1) CA1010866A (sv)
CH (1) CH587843A5 (sv)
CS (1) CS189678B2 (sv)
DD (1) DD114950A5 (sv)
DE (1) DE2457911A1 (sv)
DK (1) DK135376B (sv)
EG (1) EG11404A (sv)
ES (1) ES432483A1 (sv)
FI (1) FI59799B (sv)
FR (1) FR2253750B1 (sv)
GB (1) GB1464583A (sv)
HK (1) HK28379A (sv)
IE (1) IE40204B1 (sv)
IL (1) IL46102A (sv)
IN (1) IN140460B (sv)
KE (1) KE2933A (sv)
LU (1) LU71427A1 (sv)
MY (1) MY7900247A (sv)
NL (1) NL7415793A (sv)
NO (1) NO141898C (sv)
PH (1) PH10594A (sv)
PL (1) PL94120B1 (sv)
RO (1) RO65957A (sv)
SE (1) SE411348B (sv)
SU (1) SU563914A3 (sv)
YU (1) YU36948B (sv)
ZA (1) ZA747593B (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4060615A (en) * 1976-02-18 1977-11-29 Mead Johnson & Company 2-Piperazinyl-6,7-dimethoxyquinazolines
US4001237A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company Oxazole, isoxazole, thiazole and isothiazole amides
US4001238A (en) * 1976-02-18 1977-01-04 Bristol-Myers Company 1,3,4-oxadiazole amides
SE435380B (sv) 1976-06-15 1984-09-24 Pfizer Forfarande for framstellning av kinazolinforeningar
US4062844A (en) * 1976-09-20 1977-12-13 Pfizer Inc. Process for preparing hypotensive 2-(4-aroylpiperazin-1-yl)-amino-6,7-dimethoxyquinazolines
FI58124C (fi) * 1976-12-15 1980-12-10 Orion Yhtymae Oy Ny mellanprodukt 3,4-dimetoxi-6-(4-(2-furoyl)-1-piperazinyltiokarbamido)-bensonitril foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande verkan
FI58125C (fi) * 1976-12-15 1985-01-02 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolin med blodtryckssaenkande vekan
US4138561A (en) * 1977-09-30 1979-02-06 Bristol-Myers Company Cyanocarboxamidines and quinazoline process
DK153878C (da) * 1978-05-18 1989-02-06 Pfizer Fremgangsmaade til fremstilling af 2'-methyl-2'-hydroxy-propyl-piperazin-1-carboxylatforbindelser
FI67699C (fi) * 1979-01-31 1985-05-10 Orion Yhtymae Oy Foerfarande foer framstaellning av 6,7-dimetoxi-4-amino-2-(4-(2-furoyl)-1-piperazinyl)kinazolinhydroklorid med blodtryckssaenkande verkan
US4426382A (en) 1980-02-13 1984-01-17 Sankyo Company Limited 4-Amino-6,7-dimethoxy-2-piperazinylquinazoline derivatives, their preparation and use
US4351832A (en) * 1980-04-18 1982-09-28 American Home Products Corporation 2-(Piperazinyl)-4-pyrimidinamines
US4333937A (en) * 1980-04-18 1982-06-08 American Home Products Corp. 2-(Piperazinyl)-4-pyrimioinamines
FI70411C (fi) * 1980-12-29 1986-09-19 Pfizer Foerfarande foer framstaellning av nya antihypertensiva 4-amino-6,7-dimetoxi-2-piperazinokinazolin derivat
FI79107C (sv) * 1984-06-25 1989-11-10 Orion Yhtymae Oy Förfarande för framställning av stabil -form av prazosinhydroklorid.
CA2077252C (en) 1992-08-31 2001-04-10 Khashayar Karimian Methods of making ureas and guanidines, and intermediates therefor
EP0794178A4 (en) * 1994-11-25 1998-02-25 Nippon Chemiphar Co CHINAZOLIN DERIVATIVES
US6313294B1 (en) 1998-02-04 2001-11-06 Development Center For Biotechnology Process for preparing amides
US20070086958A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Formation of medically useful gels comprising microporous particles and methods of use
US20070087061A1 (en) * 2005-10-14 2007-04-19 Medafor, Incorporated Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines

Also Published As

Publication number Publication date
NO141898B (no) 1980-02-18
IL46102A (en) 1977-12-30
ES432483A1 (es) 1976-11-16
CS189678B2 (en) 1979-04-30
SE7413960L (sv) 1975-06-06
LU71427A1 (sv) 1975-08-20
DE2457911A1 (de) 1975-06-12
ATA970274A (de) 1977-08-15
ZA747593B (en) 1975-12-31
CH587843A5 (sv) 1977-05-13
IN140460B (sv) 1976-11-13
SU563914A3 (ru) 1977-06-30
AT342598B (de) 1978-04-10
BE822873A (fr) 1975-06-03
NL7415793A (nl) 1975-06-09
FI351474A (sv) 1975-06-06
DK135376C (sv) 1977-09-26
YU317874A (en) 1982-06-18
PH10594A (en) 1977-07-15
CA1010866A (en) 1977-05-24
YU36948B (en) 1984-08-31
MY7900247A (en) 1979-12-31
AU7553874A (en) 1976-05-20
PL94120B1 (sv) 1977-07-30
EG11404A (en) 1978-03-29
IL46102A0 (en) 1975-02-10
NO744382L (sv) 1975-06-30
DD114950A5 (sv) 1975-09-05
FR2253750A1 (sv) 1975-07-04
DK135376B (da) 1977-04-18
US3935213A (en) 1976-01-27
HK28379A (en) 1979-05-11
FI59799B (fi) 1981-06-30
GB1464583A (en) 1977-02-16
AR207766A1 (es) 1976-10-29
SE411348B (sv) 1979-12-17
DK629874A (sv) 1975-07-21
IE40204B1 (en) 1979-04-11
JPS5093987A (sv) 1975-07-26
KE2933A (en) 1979-03-30
FR2253750B1 (sv) 1977-10-28
IE40204L (en) 1975-06-05
RO65957A (fr) 1979-07-15

Similar Documents

Publication Publication Date Title
NO141898C (no) Fremgangsmaate for fremstilling av 6,7-dimetoksy-4-amino-2-(4-(2-furoyl)-piperazin-1-yl)-kinazolin
SE422325B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
NO142397C (no) Analogifremgangsmaate for fremstilling av 6,11-dihydro-11-oksodibenz (b,e)-oksepineddiksyrer
SE435713B (sv) Forfarande for framstellning av 1,3-bensoxazoler
YU50479A (en) Process for preparing novel 4-(2-imidazoline-2-yl-amino)-2,1,3-benzothiadizzole derivatives
SE419750B (sv) Forfarande for framstellning av 6-acyl-2,4-dialkyl-2-hydroxicyklohexan-1,35-trion
SE420720B (sv) Forfarande for framstellning av 2,6-disubstuerade fenylaminoguanidinforeningar
NO137897C (no) Fremgangsmaate til fremstilling av optisk aktive 1,4-benzdiazepin-2-on-derivater
SE429237B (sv) Forfarande for framstellning av 9,3",4"-tri-alkanoyl sf-837 m,-derivat
FI56011C (fi) Foerfarande foer framstaellning av 2-(1-piperazinyl)- eller 2-(4-alkyl-1-piperazinyl)-8-etyl-5,8-dihydro-5-oxopyrido (2,3-d)-pyrimidin-6-karboxylsyror
SE419443B (sv) Forfarande for framstellning av nya 2,4 diamino-5-bensylpyrimidinderivat
SE416053B (sv) Forfarande for framstellning av 7alfa-metylostr-4-en-3alfa, 17beta-diol
SE421313B (sv) Forfarande for framstellning av 2-(fenoxialkyltio)-5-nitroimidazoler
SE7408978L (sv) Forfarande for framstellning av ny heterocykliska foreningar.
SE419444B (sv) Forfarande for framstellning av nya 2,4-diamino-5-bensylpyrimidinderivat
SE402105B (sv) Forfarande for framstellning av 2-amino-5-alkyl-1,3,4-tiadiazoler
SE402292B (sv) Forfarande for framstellning av nya 4-hydroxi-4-(3,4-metylendioxifenyl)-piperidiner
SE401833B (sv) Forfarande for framstellnig av vissa angivna 1,2,4-friazolderivat
TR18199A (tr) Yeni 3, 4-dihidro-1, 2, 4-triazinlerin hazirlanmasina mahsus usul
SE419980B (sv) Forfarande for framstellning av eventuellt substituerade 2-fenyl-bicyklo /2,2,2/okt-3-ylalkylaminer
SE431325B (sv) Forfarande for framstellning av 6-substituerade 2,3-dimetoxi-5-metyl-1,4-bensokinoner
SE420600B (sv) Forfarande for framstellning av 1,2,3,4-tetrahydroisokinoliner
SE412910B (sv) Forfarande for framstellning av derivat av 1,3-bensodioxol
SE402920B (sv) Forfarande for framstellning av nya 21-alkylerade 16alfa, 17alfa-alkylidendioxi-pregn-4-en-3,20-dioner
SE413025B (sv) Forfarande for framstellning av nya 6,7-bensomorfanderivat